AI in Drug Repurposing Market Will Grow Rapidly In Coming Years
Drug repurposing is emerging as an important strategy in modern pharmaceutical research because it can identify new therapeutic uses for existing medicines and potentially reduce the time, cost, and uncertainty associated with conventional drug development. The latest trend is the integration of artificial intelligence, machine learning, generative AI, and large-scale biomedical datasets into repurposing workflows. AI systems can analyze relationships between drugs, diseases, genes, proteins, clinical records, and molecular pathways to identify potential treatment opportunities. At the same time, the AI pharmaceutical industry is moving toward more integrated discovery platforms that combine computational prediction with laboratory and clinical validation. As per research, The global artificial intelligence in drug repurposing market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.7 billion in 2026, at a CAGR of 24.5% from 2026 to 2033. Rising dema...